GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hadasit Bio Holdings Ltd (XTAE:HDST-M) » Definitions » Capex-to-Operating-Income

Hadasit Bio Holdings (XTAE:HDST-M) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Hadasit Bio Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Hadasit Bio Holdings's Capital Expenditure for the six months ended in Dec. 2023 was ₪0.00 Mil. Its Operating Income for the six months ended in Dec. 2023 was ₪-0.94 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Hadasit Bio Holdings Capex-to-Operating-Income Historical Data

The historical data trend for Hadasit Bio Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hadasit Bio Holdings Capex-to-Operating-Income Chart

Hadasit Bio Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hadasit Bio Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hadasit Bio Holdings's Capex-to-Operating-Income

For the Biotechnology subindustry, Hadasit Bio Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hadasit Bio Holdings's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hadasit Bio Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Hadasit Bio Holdings's Capex-to-Operating-Income falls into.



Hadasit Bio Holdings Capex-to-Operating-Income Calculation

Hadasit Bio Holdings's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -1.781
=N/A

Hadasit Bio Holdings's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.943
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hadasit Bio Holdings  (XTAE:HDST-M) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Hadasit Bio Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Hadasit Bio Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Hadasit Bio Holdings (XTAE:HDST-M) Business Description

Traded in Other Exchanges
Address
5th Floor, Jerusaelm Bio-Park, Hadassah Ein-Kerem Campus, Jerusalem, ISR, 91120
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.

Hadasit Bio Holdings (XTAE:HDST-M) Headlines

No Headlines